1. Discovery Research, sanofi-aventis, 1041 Route 202/206 N, Bridgewater, NJ 08807, USA;2. R&D Lead Identification Frankfurt, sanofi-aventis, Industriepark Hoechst, Frankfurt am Main 65926, Germany
Abstract:
Biochemical and X-ray crystallographic studies confirmed that hydroxyquinoline derivatives identified by virtual screening were actually covalent inhibitors of the MIF tautomerase. Adducts were formed by N-alkylation of the Pro-1 at the catalytic site with a loss of an amino group of the inhibitor.